The R168G heterozygous mutation of tropomyosin 3 (TPM3) was identified in three family members and has manifestations ranging from asymptotic to serve scoliosis and respiratory complications

Kiphuth, 2010, Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation, J Neurol, 257, 658, 10.1007/s00415-009-5413-y Ohlsson, 2009, TPM3 mutation in one of the original cases of cap disease, Neurology, 72, 1961, 10.1212/WNL.0b013e3181a82659 Clarke, 2008, Mutations in TPM3 are a common cause of congenital fiber type disproportion, Ann Neurol, 63, 329, 10.1002/ana.21308 Marttila, 2014, Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies, Hum Mutat, 35, 779, 10.1002/humu.22554 Citirak, 2014, Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy, Neuromuscul Disord, 24, 325, 10.1016/j.nmd.2013.12.008 Barua, 2013, Periodicities designed in the tropomyosin sequence and structure define its functions, BioArchitecture, 3, 51, 10.4161/bioa.25616 Perry, 2001, Vertebrate tropomyosin: distribution, properties and function, J Muscle Res Cell Motil, 22, 45, 10.1023/A:1010303732441 Fidzianska, 2014, Is mutation p.Arg168Gly in TPM3 gene responsible for type 1 fiber hypoplasia and cap structure formation, Clin Neuropathol, 33, 61, 10.5414/NP300657 Kee, 2008, Tropomyosins in skeletal muscle diseases, Adv Exp Med Biol, 644, 143, 10.1007/978-0-387-85766-4_12 Lawlor, 2010, Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion, Hum Mutat, 31, 176, 10.1002/humu.21157 McLachlan, 1975, Tropomyosin coiled-coil interactions: evidence for an unstaggered structure, J Mol Biol, 98, 293, 10.1016/S0022-2836(75)80119-7 Yuen, 2015, Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres, Hum Mol Genet, 24, 6278, 10.1093/hmg/ddv334 Moraczewska, 2019, Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding, FEBS J, 286, 1877, 10.1111/febs.14787 Winter, 2016, Mutation-specific effects on thin filament length in thin filament myopathy, Ann Neurol, 79, 959, 10.1002/ana.24654 Memo, 2013, Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function, J Muscle Res Cell Motil, 34, 165, 10.1007/s10974-013-9344-y Li, 2011, Tropomyosin position on F-actin revealed by EM reconstruction and computational chemistry, Biophys J, 100, 1005, 10.1016/j.bpj.2010.12.3697 Marston, 2016, Why is there a limit to the changes in myofilament Ca2+-sensitivity associated with myopathy causing mutations, Front Physiol, 7, 10.3389/fphys.2016.00415 Tajsharghi, 2007, Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2), Arch Neurol, 64, 1334, 10.1001/archneur.64.9.1334 Lehtokari, 2007, Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2, Neuromuscul Disord, 17, 433, 10.1016/j.nmd.2007.02.015 Leelarungrayub, 2017, Simple artificial training device for respiratory muscle strength and lung volumes in healthy young male and female subjects: a pilot study, J Bodyw Mov Ther, 21, 995, 10.1016/j.jbmt.2016.11.012 Vitacca, 2019, Non-invasive ventilation as an adjunct to exercise training in chronic ventilatory failure: a narrative review, Respiration, 97, 3, 10.1159/000493691 Schieren, 2017, Anaesthetic management of patients with myopathies, Eur J Anaesthesiol, 34, 641, 10.1097/EJA.0000000000000672 Buisán, 2018, Anaesthetic management of a paediatric patient with congenital fibre type disproportion myopathy, Rev Esp Anestesiol Reanim, 65, 469, 10.1016/j.redar.2018.03.003 Jungbluth, 2017, Current and future therapeutic approaches to the congenital myopathies, Semin Cell Dev Biol, 64, 191, 10.1016/j.semcdb.2016.08.004 Lee, 2017, Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine, Genes Dis, 4, 43, 10.1016/j.gendis.2017.04.001 Ravenscroft, 2017, New era in genetics of early-onset muscle disease: breakthroughs and challenges, Semin Cell Dev Biol, 64, 160, 10.1016/j.semcdb.2016.08.002